DUSP6 and myocardial infarction: Our findings explicitly highlight that Dusp6 deficiency attenuates the tissue injury after MI rather than the ischemic necrosis and reperfusion injury, thus improving the outcome of post-MI cardiac repair by suppressing neutrophil cytotoxicity while having minimal effects on other immune cells.